Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial
A. K. Stewart, R. Vescio, G. Schiller, O. Ballester, S. Noga, H. Rugo, C. Freytes, E. Stadtmauer, S. Tarantolo, F. Sahebi, P. Stiff, J. Meharchard, R. Schlossman, R. Brown, H. Tully, M. Benyunes, C. Jacobs, R. Berenson, M. White, J. DipersioK. C. Anderson, J. Berenson
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial'. Together they form a unique fingerprint.